A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease
Context Non alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD represents a spectrum of liver disease ranging from reversible hepatic steatosis, to non alcoholic steato-hepatitis (NASH) and cirrhosis. The potential role of glucocorticoids (GC) in the...
Main Authors: | Ahmed, A, Rabbitt, E, Brady, T, Brown, C, Guest, P, Bujalska, I, Doig, C, Newsome, P, Hubscher, S, Elias, E, Adams, D, Tomlinson, J, Stewart, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2012
|
Similar Items
-
A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.
by: Adeeba Ahmed, et al.
Published: (2012-01-01) -
Cortisol Metabolism and Hepatic Expression of 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Patients with Non Alcoholic Fatty Liver Disease.
by: Ahmed, A, et al.
Published: (2010) -
Pathogenesis of non-alcoholic fatty liver disease.
by: Dowman, J, et al.
Published: (2010) -
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2011) -
11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.
by: Bujalska, I, et al.
Published: (2002)